W e would like to thank Dr. Byrne for his comments regarding our recent publication exploring the effects of a single injection versus two types of continuous infusion for femoral nerve block [1] .
We agree that Brodner and colleagues [3] previously have concluded that ropivacaine 0.2% and ropivacaine 0.3% were equivalent in terms of pain outcomes compared to ropivacaine 0.1% when used as continuous infusion for femoral nerve blocks. However, Brodner and colleagues designed their study to test the hypothesis that ropivacaine 0.3% was superior to ropivacaine 0.2% or 0.1%, and the authors' conclusion that 0.1% was ineffective was based on an interim statistical analysis of only 20 patients. Although their study demonstrated that increasing the concentration of ropivacaine above 0.2% did not confer any advantage, we relied on another study, that of Paauwe et al [4] , to address the effect of decreasing the concentration of ropivacaine below 0.2%. Indeed, Paauwe and colleagues [4] found no advantage in using concentrations of ropivacaine less than 0.1%. In designing our protocol, we were also mindful that Brodner and colleagues had not used a comprehensive multimodal analgesia strategy. The lack of benefits associated with increased concentrations of ropivacaine (ie greater than 0.1%) recently has been confirmed in another study [2] .
We recognize that we used a lower total mass of local anesthetic for both the priming injection and for the continuous infusion compared to what has been published recently by Spangehl and colleagues [5] . Such differences in postoperative 
